Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer
Clinical trial NCT06939439 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06939439
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-31
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.